• Explore /
  • Poster
  • / Clinical utility of upfront circulating tumor DNA (ctDNA) genotyping to guide first-line therapy in patients (pts) with metastatic colorectal cancer (mCRC): A GOZILA substudy.

Clinical utility of upfront circulating tumor DNA (ctDNA) genotyping to guide first-line therapy in patients (pts) with metastatic colorectal cancer (mCRC): A GOZILA substudy.

Abstract Poster

Authors

null

Yu Aoki

Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan

Yu Aoki , Yoshiaki Nakamura , Yoshito Komatsu , Hiroya Taniguchi , Yu Sunakawa , Manabu Shiozawa , Chiyoe Kitagawa , Takashi Ohta , Nobuhisa Matsuhashi , Kentaro Yamazaki , Shogen Boku , Naoki Takahashi , Taito Esaki , Hisato Kawakami , Yoshinori Kagawa , Tomohiro Nishina , Kensei Yamaguchi , Hideaki Bando , Takayuki Yoshino

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session C: Cancers of the Colon, Rectum, and Anus

Track

Colorectal Cancer,Anal Cancer

Sub Track

Translational Research

Citation

J Clin Oncol 42, 2024 (suppl 3; abstr 157)

DOI

10.1200/JCO.2024.42.3_suppl.157

Abstract #

157

Poster Bd #

K5

Abstract Disclosures

Similar Posters

First Author: Manuel Benavides

First Author: Jonathan M. Loree

First Author: Scott Kopetz

First Author: Scott Kopetz